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The lysyl hydroxylase (LH) family of enzymes has important roles in the biosynthesis of collagen. In this
paper we present the ﬁrst description of Drosophila LH3 (dPlod), the only lysyl hydroxylase encoded in the
ﬂy genome. We have characterised in detail the developmental expression patterns of dPlod RNA and pro-
tein during embryogenesis. Consistent with its predicted function as a collagen-modifying enzyme, we
ﬁnd that dPlod is highly expressed in type-IV collagen-producing cells, particularly the haemocytes
and fat body. Examination of dPlod subcellular localisation reveals that it is an endoplasmic reticulum
resident protein, that partially overlaps with intracellular type-IV collagen. Furthermore, we show that
dPlod is required for type-IV collagen secretion from haemocytes and fat body, and thus establish that
LH3 enzyme function is conserved across widely separated animal phyla. Our ﬁndings, and the new tools
we describe, establish the ﬂy as an attractive model in which to study this important collagen biosynthe-
sis enzyme.
 2010 Elsevier B.V. Open access under CC BY license.Basement membranes are thin mats of specialised extracellular
matrix that underlie epithelial sheets and tubes. They provide scaf-
fold support for cell adhesion, cell migration and changes in cell
and tissue morphology, they provide interactive surfaces for cell
signalling, and they act as selective ﬁltration barriers (Hudson
et al., 1993; Hutter et al., 2000; Schneider and Granato, 2006;
Vasilyev et al., 2009; Wang et al., 2008). Type-IV collagen is an
important and evolutionarily ancient constituent of all basement
membranes, forming a ﬂexible, multi-layered extracellular mesh-
work (Boute et al., 1996; Yurchenco et al., 2004). Macromolecular
assembly and secretion of type-IV collagen is dependent upon mul-
tiple co- and post-translational modiﬁcations. These include pro-
cessing of lysine residues by the lysyl hydroxylase (LH) enzyme
family. Members of this family (also referred to as PLOD or procol-
lagen-lysine, 2-oxoglutarate 5-dioxygenase) catalyze the hydroxyl-
ation of lysine residues in collagens and other proteins containing
collagenous-like domains. To date, three LH genes (LH1, LH2 and
LH3) have been identiﬁed in vertebrates and a single LH (LH3) in
invertebrates (Myllyharju and Kivirikko, 2004; Myllyla et al.,
2007). LH3 is a multifunctional enzyme that, in addition to its LH
activity, is capable of catalysing the glycosylation of hydroxylysyl
residues to produce either monosaccharide (galactose) or disaccha-
ride (glucose-galactose) derivatives (Heikkinen et al., 2000;
Rautavuoma et al., 2002; Ruotsalainen et al., 2006; Wang et al.,
2002a,b). The importance of the LH family for collagen biosynthe-; fax: +44 (0) 1223 336676.
 license.sis in humans is underlined by a number of connective tissue
diseases that are associated with mutations in LH genes. These in-
clude Ehlers-Danlos syndrome type VI for LH1 (Steinmann et al.,
1993; Yeowell and Walker, 2000), Bruck syndrome for LH2
(Ha-Vinh et al., 2004; van der Slot et al., 2003) and a severe connec-
tive tissue disorder whose features overlap with known collagen
disorders for LH3 (Salo et al., 2008).
Modiﬁcation of lysine residues in collagen polypeptides fosters
the generation of cross-links which are necessary for collagen
chain assembly into supramolecular complexes. For example, type
IV and type VI collagens are highly decorated by lysine modiﬁca-
tions that are important for their assembly into tetramers (Sipilä
et al., 2007). In the absence of modiﬁcation collagen secretion is
impaired and instead accumulates to high and cytotoxic levels
within the cell. In LH3 knock-out mice type-IV collagen secretion
fails and the severe basement membrane formation defects that
occur as a result lead to embryonic lethality (Rautavuoma et al.,
2004; Ruotsalainen et al., 2006). Even a moderate reduction in
LH3 activity, in humans or mice deﬁcient for just one LH3 allele, re-
sults in defects in deposition and organisation of extracellular ma-
trix (Risteli et al., 2009). The function of LH3 appears to be widely
conserved because collagen secretion is also impaired and is absent
from basement membranes in LH3 mutant ﬁsh (diwanka mutants,
(Schneider and Granato, 2006) and worms (let-268 mutants,
Norman and Moerman, 2000).
LH3 is widely expressed during mouse embryogenesis but
becomes more restricted to speciﬁc cells within adult tissues such
as brain, lungs, spleen, muscle, pancreas, kidney and liver (Salo
et al., 2006a). Immuno-electron microscopy reveals that LH3
S. Bunt et al. / Gene Expression Patterns 11 (2011) 72–78 73localises intracellularly within the endoplasmic reticulum (ER)
(Salo et al., 2006a). In addition, LH3 is secreted into the extracellu-
lar space surrounding some tissues such as kidney, spleen, muscle
and liver (Salo et al., 2006a,b). Studies in cultured cells indicate
that LH3 is secreted from cells and located both in the medium
and on the cell surface, where it is associated with collagenous pro-
teins (Salo et al., 2006b). These data suggest that collagen modiﬁ-
cation by LH3 may occur both inside and outside the cell. In early
zebraﬁsh embryos LH3 is expressed ubiquitously until gastrulation
when it becomes concentrated in the axial mesoderm. It is ex-
pressed strongly in the notochord and at low levels throughoutFig. 1. Protein alignment of LH3 proteins across the animal kingdom. (A) ClustalW prote
acids are indicated by coloured boxes, with dark/light shading representing degree of con
mark amino acids required for Fe2+ binding and LH activity (magenta) as assayed for LH1
GGT activities (position 223, orange); worm mutations in let-268 (positions 668 and 682
underlined in green corresponds to the DXD motif, a region important for GGT activity.
represents the 2-oxogluatarate binding site. (B) Cladogram representing relationships bet
is shown (generated by BLASTP).the myotome (Schneider and Granato, 2006). In the worm LH3 is
detected in the body wall muscles and in glial-like cells where it
coincides with the expression of type-IV collagen (Norman and
Moerman, 2000).
Here we describe the embryonic expression pattern for Dro-
sophila LH3 (dPlod), the only lysyl hydroxylase encoded in the ﬂy
genome, using a combination of in situ hybridisation, antibody
staining (using a commercially available LH3 cross-reactive anti-
body raised against human LH3), and a GAL4 enhancer-trap line.
We show that dPlod is strongly expressed in cells and tissues that
produce and secrete high levels of type-IV collagen where itin alignment of human, mouse, zebraﬁsh, worm and ﬂy LH3. Shared identical amino
servation for each amino acid between the ﬁve species. Asterisks above the sequence
and LH3; a disease-causing mutation in a LH3 human patient with reduced GT and
, red); residues important for GGT activity in humans and worms (green). Sequence
Sequence underlined in black represents the putative ER-retention signal. Black dot
ween human, mouse, ﬁsh, worm and ﬂy LH3. The percentage of amino acid identity
74 S. Bunt et al. / Gene Expression Patterns 11 (2011) 72–78partially colocalises with intracellular type-IV collagen in the ER,
consistent with its established function in other organisms as a
type-IV collagen-modifying enzyme. Finally, using a deﬁciency
that removes the dPlod locus we show that dPlod is required for
collagen secretion. These data and the novel tools we describe pro-
vide a new, genetically tractable model with which to dissect the
function and regulation of this important collagen-modifying
enzyme.
1. Results
1.1. dPlod is a Drosophila lysyl hydroxylase
The ﬂy genome contains a single lysyl hydroxylase gene anno-
tated as CG6199 that we refer to here as Drosophila Plod or dPlod.
It maps to cytological position 68B1 on the left arm of the third
chromosome and the genomic locus spans 7.9 kb. Two annotated
transcripts, CG6199-RA and CG6199-RB, 2660 and 2574 nucleo-Fig. 2. Embryonic dPlod expression. A-F, RNA in situ hybridisation (left panel) and dPl
showing that dPlod is not found in the early embryo. (B) Stage 13 embryo, dPlod is dete
(black arrowheads) and adjacent to the CNS (white arrowheads) are indicated. (C) Ventral
(D) lateral view of a stage 15 embryo showing high levels of dPlod expression in the fat bo
the fat body (arrowheads). (F) dorsal view of stage 17 embryos. (G) Higher magniﬁcation
gut in a stage 17 embryo (arrowheads). (I) High magniﬁcation view of a stage 16 embryo
or homozygous dPlod deﬁcient (K) embryos stained for dPlod (red) and GFP (green). Hom
p{GAWB}NP5633 GAL4 insertion line crossed to UAS-nuclearLacZ. Stage 16 embryos sho
and anal pads (asterisk). Lateral (L) and ventral (M) views are shown. In all ﬁgures antetides in length differ by only 86 nucleotides in their 50UTR. Concep-
tual translation of these transcripts yields a 721 amino acid protein
with a predicted molecular weight of 82.5 kDa. Protein alignment
with LH genes from other species indicates that dPlod is more clo-
sely related to vertebrate LH3-type and worm LH3 than either of
the LH1- or LH2-type genes. dPlod possesses on average 45%
identity and 66% similarity with LH3 proteins from humans,
mice, ﬁsh and worms, with the carboxyl-terminal region having
the highest level of conservation (Fig. 1A). A putative ER-retention
signal at the extreme C-terminus of dPlod is highly conserved. The
phylogenetic relationships between human, mouse, ﬁsh, worm and
ﬂy LH3 are shown in the cladogram (Fig. 1B).
Several key residues required for the different LH3 enzymatic
activities are conserved in dPlod. The carboxyl-terminal region of
LH3 proteins corresponds to the lysyl hydroxlase active site. This
site, that constitutes (i) the Fe2+ binding site including histidine
and aspartate residues at positions His656/667, Asp658/669 and
His708/719 in human LH1/LH3, respectively (Pirskanen et al.,od antibody staining (right panel) in Drosophila embryos. (A) Cellular blastoderm,
cted at high levels in haemocytes throughout the embryo. Haemocytes in the head
view of a stage 15 embryo showing dPlod expressing haemocytes outlining the CNS.
dy (arrowheads). (E) Dorsal view of a stage 15 embryo showing dPlod expression in
of embryo shown in B. (H) High magniﬁcation view of haemocytes surrounding the
showing dPlod protein expression in the anal pad. J and K, Stage 16 sibling control (J)
ozygous dPlod deﬁcient embryos were identiﬁed by absence of CtB-GFP. (L) and (M),
wing expression in fat body (yellow arrowhead), haemocytes (magenta arrowhead)
rior is to the left.
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acid positions 650, 652 and 702, respectively); and, (ii) the arginine
residue that binds the C-5 carboxyl group of 2-oxoglutarate (a co-
substrate required for hydroxylation activity) (Passoja et al., 1998)
is conserved in dPlod (positions 729 and 712 in human and ﬂy
LH3). The sites of glycosyltransferase activity have been mapped
to the amino-terminal region of vertebrate LH3. In human LH3,
site-directed mutagenesis of cysteine 144 and leucine 208 leads
to signiﬁcant reduction in glycosyltransferase activity when tested
in vitro (Wang et al., 2002a,b). These residues are conserved in
dPlod (Cys133 and Leu197). In addition, three out of ﬁve aspartates
in the so-called D-rich region, which is also indispensable for gly-
cosyltransferase activities, are conserved in dPlod (Wang et al.,
2002a,b). Our in silico analyses strongly suggest that ﬂy dPlod pos-
sesses lysyl hydroxlase and glycosyltransferase activities demon-
strated previously for LH3 enzymes from other species.1.2. Embryonic expression of dPlod
We performed in situ hybridization to determine the expression
pattern of dPlod during embryonic development (left panel, Fig. 2).
We ﬁnd little or no dPlod in early embryos (Fig. 2A). Expression is
ﬁrst detected at around stage 12 in haemocytes, where it accumu-
lates at high levels by stage 13 (Fig. 2B). At this stage dPlod is found
in haemocytes populating the whole embryo including those in the
head and those surrounding the CNS (Fig. 2B, arrowheads). dPlod
expression in haemocytes continues throughout embryogenesis,
becoming particularly high at stages 15–17. For example Fig. 2C
shows high dPlod expression in haemocytes surrounding the CNS
at stage 15. During stage 13 dPlod is also detected in the developing
fat body and by later stages accumulates at high levels in this tis-
sue (Fig. 2D–F, stage 15 and 17 shown).
To determine the embryonic expression pattern of the dPlod
protein, we performed antibody staining using the anti-PLOD3
polyclonal antibody originally raised against human PLOD3
(Fig. 2A–F, right panel). This antibody displays signiﬁcant cross-
reactivity to dPlod and produces a protein expression pattern very
similar to the RNA expression pattern described above. We do notFig. 3. dPlod is expressed in type-IV collagen-producing cells. (A–C) Stage 16 VkgGFP em
protein are detected in haemocytes (A) and fat body (B) coincident with high levels of Vkg
partial overlap between Vkg-GFP and dPlod. Anterior is to the left, dorsal up.ﬁnd dPlod protein in early embryos (Fig. 2A). In accordance with
observations made for dPlod RNA, dPlod protein is ﬁrst detected
in haemocytes during stage 12. By stage 13 dPlod is detected at
high levels in haemocytes throughout the embryo (Fig. 2B). A high-
er magniﬁcation view of the dPlod expression in the haemocytes in
the head at stage 13 and around the midgut at stage 17 are shown
in Figs. 2G and H. Fat body expression of dPlod is found from stage
13. It continues to be expressed in the fat body throughout
embryogenesis with very robust staining found at later stages
(Fig. 2D–F). We also detect high levels of dPlod in the anal pads
in late embryos (stage 16, Fig. 2I). We were unable to detect any
staining in embryos homozygous for a deﬁciency that uncovers
the dPlod locus, conﬁrming the speciﬁcity of the dPlod antibody
(Fig. 2K compared to sibling control embryo, Fig. 2J).
The P-element Gal4 line NP5633 (Drosophila Genetic Resource
Centre, Kyoto) maps to the 50 end of the dPlod locus. We examined
the expression pattern of NP5633 to determine if it recapitulates
endogenous dPlod expression. We ﬁnd that NP5633 drives expres-
sion in haemocytes, fat body and anal pads in late embryos that
closely mirrors the expression pattern we see for dPlod RNA and
protein (Fig. 2L and M). These data further conﬁrm the expression
patterns described above and provide a useful tool that permits ge-
netic manipulation of dPlod.1.3. dPlod is expressed in collagen-producing cells
In other species, LH3 is expressed and its activity is required
within collagen-producing cells where it facilitates the assembly
and secretion of collagens – particularly type IV and type VI colla-
gens. There are two type IV (but no type VI) collagen genes in
Drosophila, Viking and Cg25C, which are expressed predominantly
in haemocytes and fat body (Le Parco et al., 1986a,b; Yas-
othornsrikul et al., 1997). Collagen secreted by these cells contrib-
utes to the basement membrane of many tissues in the embryo. To
test if dPlod is expressed in collagen-producing cells in the ﬂy, we
double stained embryos for dPlod (anti-PLOD3) and for type-IV
collagen, using Viking-GFP as a representative type-IV collagen
(Vkg-GFP, Morin et al., 2001). Vkg-GFP is a GFP protein-trap andbryos double stained for GFP (green) and dPlod (magenta). High levels of the dPlod
-GFP production and secretion. (C) High magniﬁcation view of haemocytes showing
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tein. We ﬁnd that dPlod is co-expressed with GFP in haemocytes
and fat body (Fig. 3A and B). A higher magniﬁcation view of hae-
mocytes shows that dPlod has a perinuclear localisation that par-
tially overlaps with intracellular Vkg-GFP (Fig. 3C). The high level
of dPlod in collagen-producing cells is consistent with previous
observations made in other species, and with its predicted function
as a collagen biosynthesis enzyme.1.4. Subcellular localization of dPlod
In mice LH3 protein is located intracellularly within the endo-
plasmic reticulum (ER) and it is also secreted and found in the
extracellular space (Salo et al., 2006b; Wang et al., 2009). We
examined the subcellular localization of dPlod in the fat body
and haemocytes at high resolution. We ﬁnd that dPlod localization
overlaps substantially with a marker for the ER (EYFP-ER,
LaJeunesse et al., 2004) in fat body cells and haemocytes (Fig. 4A
and B). Localization of dPlod is consistent with its possession of a
putative ER-retention signal (Fig. 1A). In contrast, double staining
for dPlod with a Golgi speciﬁc marker (EYFP-Golgi, LaJeunesseFig. 4. Subcellular localisation of dPlod. (A) and (B) dPlod localises to the ER. dPlod (red
green). (C) In contrast there is no overlap between dPlod (green) and a Golgi apparatus m
two individual fat body cells are marked with asterisks). (D) dPlod (magenta) expression i
detected within haemocytes and extracellular puncta in areas surrounding haemocyteset al., 2004) demonstrates that dPlod is absent from this cellular
compartment (Fig. 4C). In addition, examination of haemocytes
at high magniﬁcation revealed dPlod-positive staining in small
puncta in the extracellular space surrounding haemocytes
(Fig. 4D). This staining was not exclusively found in the extracellu-
lar space surrounding haemocytes but was more concentrated here
than in haemocyte-free regions within the body cavity (data not
shown). These observations suggest that dPlod, similar to mouse
LH3 (Salo et al., 2006b; Wang et al., 2009), is secreted into the
extracellular space and may act to further modify collagen within
this compartment.1.5. dPlod is required for type-IV collagen secretion
LH3 activity is critical for the biosynthesis of type-IV collagen in
humans, mice, ﬁsh and worms (Schneider and Granato, 2006;
Norman and Moerman, 2000; Rautavuoma et al., 2004). In the ab-
sence of LH3, type-IV collagen is expressed but is retained within
the type-IV collagen-producing cells, indicating that processing
and/or secretion of type-IV collagen is disrupted. As a consequence,
type-IV collagen is not incorporated into basement membranes) in the fat body (A) and haemocytes (B) is coincident with an ER marker (EYFP-ER,
arker (EYFP-Golgi, red, overlap would appear yellow. Image from fat body shown;
n haemocytes (srp-Gal4, crq-Gal4, UAS-GFP; green) from a stage 16 embryo. dPlod is
(arrowheads).
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has a similar function we examined type-IV collagen distribution
(using Vkg-GFP) in embryos lacking dPlod using a deﬁciency chro-
mosome that removes the dPlod locus (and eight additional genes).
In wild-type stage 16 embryos Vkg-GFP is detected intracellularly
in haemocytes and fat body and in the basement membranes sur-
rounding most tissues including the central nervous system (CNS)
and gut (Fig. 5A). Vkg-GFP in the basement membranes is derived
largely from Vkg-GFP produced and secreted from haemocytes and
fat body (Yasothornsrikul et al., 1997). In stage 16 dPlod deﬁcient
embryos Vkg-GFP is detected in haemocytes and fat body, where
it accumulates at high levels, but in contrast to wild-type embryos
it is not secreted and is therefore absent from the basement mem-
brane of the CNS, gut and all other tissues (Fig. 5B and C). Consis-
tent with other collagen-modifying enzymes (e.g. SPARC, Martinek
et al., 2008), dPlod homozygous deﬁcient animals die as embryos
highlighting the importance of type-IV collagen secretion for nor-
mal completion of embryonic development. Whilst we cannot rule
out a role played by the other eight genes removed by the deﬁ-
ciency, this experiment strongly suggests that dPlod plays a criticalFig. 5. dPlod is required for type-IV collagen secretion. (A) Stage 16 Vkg-GFP control
embryo showing secreted Vkg-GFP in the basement membranes ensheathing most
tissues including the gut (g), central nervous system (cns) and brain (br). Vkg-GFP
expression is also detected in haemocytes (arrowheads). (B) and (C), Two different
focal plane images from a stage 16 Df(3R)vin66 mutant embryo. Vkg-GFP is not
secreted and is absent from the basement membranes surrounding internal tissues
(B), despite its expression and accumulation to high levels in haemocytes
(arrowhead) and fat body (fb) (C). Equivalent confocal settings were used to
acquire images in (A–C). Anterior to the left, dorsal up.and evolutionarily conserved role in the secretion of type-IV colla-
gen in the ﬂy.1.6. Discussion
We have provided the ﬁrst comprehensive description of the
only lysyl hydroxylase encoded in the ﬂy genome and character-
ised its embryonic expression pattern in detail. The dPlod protein
shares a high degree of sequence identity/similarity with LH3 pro-
teins from widely separated animal phyla with strongest conserva-
tion occurring in the catalytic domains. This suggests that ﬂy LH3,
like its counterparts in other species, possesses (i) lysyl hdroxylase,
(ii) glucosyltransferase, and (iii) galactosyltransferase activities.
Biochemical analysis of dPlod will be necessary to establish these
predicted enzymatic activities.
Consistent with its predicted function as a collagen-modifying
enzyme dPlod is highly expressed in type-IV collagen-producing
cells particularly haemocytes and fat body, where it localises to
the ER and partially overlaps with intracellular type-IV collagen.
This is in agreement with previous reports demonstrating that ver-
tebrate LH3 localises to the ER. Interestingly, we also detect dPlod
in the extracellular space raising the possibility that dPlod modiﬁes
extracellular collagen. There is evidence that mouse LH3 is se-
creted, and required extracellularly for normal basement mem-
brane structure (Salo et al., 2006b; Wang et al., 2009). These
extracellular function(s) of LH3 are not well characterised, and
the ﬂy could provide a useful model to examine mechanisms of
LH3 secretion and extracellular activity.
Using a genetic deﬁciency that removes dPlod we show that
dPlod activity is required in haemocytes and fat body to facilitate
collagen secretion. This function for dPlod is consistent with LH3
functions in other species fromworms to mammals, indicating that
collagen processing by LH3 enzymes is an ancient and widely con-
served feature within the animal kingdom. LH3 depletion results in
diverse developmental phenotypes whose unifying feature can be
traced to abnormalities in the basement membrane. These
phenotypes include defects in zebraﬁsh motor neuron migration
(Schneider and Granato, 2006); defects in tissue integrity in the
worm (Norman and Moerman, 2000); and global defects in base-
ment membrane assembly that correlate with general develop-
mental retardation and result in embryonic lethality in the
mouse (Rautavuoma et al., 2004; Risteli et al., 2009; Ruotsalainen
et al., 2006). In humans, mutations in the LH3 gene result in a
severe connective tissue defects with features that overlap with
collagen disorders. Although the underlying causes of this condi-
tion have not been examined in detail, it is likely that defects in
the basement membrane contribute to the disease phenotype. In
the ﬂy, mutations in dPlod are likely to have pleiotropic phenotypes
that overlap with those in collagen IV mutants or in mutations in
other genes required for collagen biosynthesis (Martinek et al.,
2008). In support of this, we have observed that renal tubule mor-
phogenesis, a processes dependent upon a haemocyte-secreted
collagen sheath surrounding the tubule, is disrupted in the absence
of dPlod and that these defects are similar to those for type-IV
collagen mutants or for mutants in collagen processing enzymes
such as dSPARC (Bunt et al., 2010; Martinek et al., 2008). This study
establishes the ﬂy as a genetically tractable model for the study of
LH3 function in development and disease.2. Experimental procedures
2.1. in situ hybridisation and immunohistochemistry
For in situ hybridisation the following primer pairs (Sigma–
Genosys) were used to generate a DNA template from genomic
78 S. Bunt et al. / Gene Expression Patterns 11 (2011) 72–78DNA using standard PCR conditions: 50-GGC AGA CGC CAT TAA
AAG TCC-30 and 50-CGC TGG ATG AGA TCT TTG AGA-30. A sense
strand probe was used as a negative control. Hybridisations were
carried out using standard protocols (Nagaso et al., 2001; Tautz
and Pfeiﬂe, 1989). For PLOD antibody staining, embryos were ﬁxed
in 8% formaldehyde and used fresh. PLOD signal was ampliﬁed
using a biotinylated secondary antibody followed ABC (vectorlabs)
and Tyramide (Perkin–Elmer) ampliﬁcation kits. The following
antibodies were used: rabbit anti-PLOD (ProteinTech Group,
1:50); goat anti-GFP (Abcam, 1:500); rabbit anti-Bgal (Cappel,
1:1000).
2.2. Fly stocks
srp-Gal4, crq-Gal4, UAS-GFP (gift from Will Wood) was used to
visualise haemocytes. Viking-GFP (Morin et al., 2001) was used
to visualise endogenous Vkg protein; EYFP-ER and EYFP-Golgi
(Bloomington stock centre) were used for ER and Golgi apparatus
markers. Df(3L)vin66 carried on the TM3 chromosome (Blooming-
ton stock centre) was used to remove the dPlod locus. This deﬁ-
ciency removes eight genes in addition to dPlod. The GAL4
insertion line used was p{GAWB}NP5633 (Kyoto stock number
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